Prophylaxis of hepatitis B after liver transplantation with antiviral(s) and immunoglobulins efficiently protect the majority of recipients; however recent experiences suggest a decline of HBsAg-positive candidates and the use of hepatitis B Immunoglobulin-free schedules.
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort / Marzano, Alfredo; Andreone, Pietro; Boccagni, Patrizia; Burra, Patrizia; Caneschi, Francesco; Conoscitore, Pasquale F; Coppola, Carmine; DE Carlis, Luciano; Fagiuoli, Stefano; Forte, Paolo; Gaeta, Giovanni B; Iemmolo, Rosa M; Lotti Suffredini, Anna; Mazzola, Michele; Merli, Manuela; Parrilli, Gianpaolo; Piai, Guido; Piras, Maria R; Salizzoni, Mauro; Tamè, Mariarosa; Tisone, Giuseppe; Toniutto, Pierluigi; Vennarecci, Giovanni; Volpes, Riccardo; Zamboni, Fausto; Caccamo, Lucio. - In: MINERVA GASTROENTEROLOGICA E DIETOLOGICA. - ISSN 1827-1642. - 64:1(2018), pp. 1-9. [10.23736/S1121-421X.17.02407-2]
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort
Andreone, Pietro;
2018
Abstract
Prophylaxis of hepatitis B after liver transplantation with antiviral(s) and immunoglobulins efficiently protect the majority of recipients; however recent experiences suggest a decline of HBsAg-positive candidates and the use of hepatitis B Immunoglobulin-free schedules.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
